Hannah Deresiewicz
Investor Relations Contact en FORTY SEVEN, INC. .
Perfil
Hannah Deresiewicz is currently working as the Head of Investor Relations at KALA BIO, Inc. and as an Investor Relations Contact at Forty Seven, Inc. She previously worked as a Senior Associate at Stern Investor Relations, Inc. starting in 2013.
Cargos activos de Hannah Deresiewicz
Empresas | Cargo | Inicio |
---|---|---|
FORTY SEVEN, INC. | Investor Relations Contact | - |
KALA BIO, INC. | Investor Relations Contact | - |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/06/2013 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KALA BIO, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Forty Seven, Inc.
Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Hannah Deresiewicz